Advertisement

Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program

Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program

On Thursday, two sources familiar with the matter told Reuters that Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) have agreed to supply a program co-led by the World Health Organization (WHO) with their COVID-19 vaccine. The COVAX program is a group effort coordinated by the WHO, the Coalition for Epidemic Preparedness Innovations (CEPI), and Gavi, the Vaccine Alliance. Details regarding the number of doses Pfizer and BioNTech have agreed to and the price per dose the COVAX program intends to pay the partners are still unclear.